about
CD38 as a prognostic marker in chronic lymphocytic leukaemia at a single New Zealand centre: patient survival in comparison to age- and sex-matched population data.Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study.Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset.Adult and juvenile dermatomyositis: are the distinct clinical features explained by our current understanding of serological subgroups and pathogenic mechanisms?Muscle Biopsy Findings in Combination With Myositis-Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis.The diagnostic utility of autoantibodies in adult and juvenile myositis.The evolving spectrum of polymyositis and dermatomyositis--moving towards clinicoserological syndromes: a critical review.Myositis specific and associated autoantibodies in the diagnosis and management of juvenile and adult idiopathic inflammatory myopathies.The evidence for immunotherapy in dermatomyositis and polymyositis: a systematic review.Comparing and contrasting clinical and serological features of juvenile and adult-onset myositis: implications for pathogenesis and outcomes.Serological subsets of juvenile idiopathic inflammatory myopathies--an update.Antibodies in juvenile-onset myositis.Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort.Capecitabine-induced acute myeloid leukaemia.Sub-phenotyping of juvenile dermatomyositis: can it assist clinical decisions?Developing standardised treatment for adults with myositis and different phenotypes: an international survey of current prescribing preferences.Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients.PReS-FINAL-2130: Antibodies to MDA5 correlate with a distinct phenotype in children with juvenile dermatomyositis, including higher risk of lung involvement and ulcerative skin disease.Erratum CorrigeThe promise, perceptions, and pitfalls of immunoassays for autoantibody testing in myositis
P50
Q33517828-EAD619A5-F403-4CBF-B4B1-D003648F6B83Q34486301-2C7444EF-2835-44D0-BE47-C2F7E77D2EDBQ34563223-66881ECF-CE17-4B23-9614-3D4D0B59F564Q36903076-188DFE77-AE25-4537-8130-914A379BC948Q37388175-0F296C5D-F119-40B7-B4D3-91C0D485D205Q38139130-C1799874-2E53-4365-8518-824AC1815A66Q38139286-6C3B5B06-1D44-4EF2-B4BA-26CC8B4F48BDQ38281749-53AEFE10-9339-4D96-8B97-B0B4E354297BQ38572045-7DDC0B73-C822-474A-A585-A046EB8567B9Q38583538-7B7810D2-BFA8-4FE5-83D4-A041BA1295AFQ38664251-5F1D06CB-0B81-4AA1-BAAB-F6611255A5B7Q38830518-E0B54E1F-1084-4EE2-A098-35037C92CCD6Q42632915-5C532122-C6FA-46A4-8A7D-3D42E11D2EBAQ45998520-96B0446C-84DC-4A65-8A15-E3082C31F370Q46860909-9C5EECE6-C0D7-4847-9DC5-15B656388B6FQ53047517-C9695357-B691-4F66-A8F5-37D9807115D8Q54470882-4F6F74FA-17F8-4E9C-A5F0-16FBD89DBB5FQ55535429-AD54D690-88E7-4ECA-A65F-15B845813A5CQ60217748-53106A65-0D94-454F-A2B5-4487E25CD260Q94946475-385413CF-0A29-4F49-AEE1-BBC51BC0C629
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sarah Tansley
@ast
Sarah Tansley
@en
Sarah Tansley
@es
Sarah Tansley
@nl
Sarah Tansley
@sl
type
label
Sarah Tansley
@ast
Sarah Tansley
@en
Sarah Tansley
@es
Sarah Tansley
@nl
Sarah Tansley
@sl
prefLabel
Sarah Tansley
@ast
Sarah Tansley
@en
Sarah Tansley
@es
Sarah Tansley
@nl
Sarah Tansley
@sl
P106
P21
P31
P496
0000-0003-4633-9598